JPH04293481A - Petri dish for cell culture - Google Patents
Petri dish for cell cultureInfo
- Publication number
- JPH04293481A JPH04293481A JP8148691A JP8148691A JPH04293481A JP H04293481 A JPH04293481 A JP H04293481A JP 8148691 A JP8148691 A JP 8148691A JP 8148691 A JP8148691 A JP 8148691A JP H04293481 A JPH04293481 A JP H04293481A
- Authority
- JP
- Japan
- Prior art keywords
- petri dish
- culture
- chitin
- cell
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004113 cell culture Methods 0.000 title claims abstract description 15
- 229920002101 Chitin Polymers 0.000 claims abstract description 31
- 229920002678 cellulose Polymers 0.000 claims abstract description 10
- 239000001913 cellulose Substances 0.000 claims abstract description 10
- 229920001661 Chitosan Polymers 0.000 claims abstract description 9
- 210000004027 cell Anatomy 0.000 abstract description 51
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 39
- 239000004793 Polystyrene Substances 0.000 abstract description 18
- 229920002223 polystyrene Polymers 0.000 abstract description 18
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 abstract description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 7
- 239000000243 solution Substances 0.000 abstract description 7
- 238000001727 in vivo Methods 0.000 abstract description 6
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 abstract description 5
- 238000012258 culturing Methods 0.000 abstract description 5
- 235000019253 formic acid Nutrition 0.000 abstract description 5
- 230000004069 differentiation Effects 0.000 abstract description 4
- 210000003494 hepatocyte Anatomy 0.000 abstract description 4
- 239000007864 aqueous solution Substances 0.000 abstract description 3
- 239000011259 mixed solution Substances 0.000 abstract description 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 abstract 3
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 description 22
- 239000000758 substrate Substances 0.000 description 14
- 210000002540 macrophage Anatomy 0.000 description 13
- 210000002950 fibroblast Anatomy 0.000 description 12
- 230000000694 effects Effects 0.000 description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethyl sulfoxide Natural products CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 7
- 210000002744 extracellular matrix Anatomy 0.000 description 7
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 6
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 6
- 239000012046 mixed solvent Substances 0.000 description 6
- 238000000879 optical micrograph Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 230000029663 wound healing Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 3
- 238000002513 implantation Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000012567 medical material Substances 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000238366 Cephalopoda Species 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- 230000021164 cell adhesion Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- RPOKRGMOEWYIKB-ZFCLCKFASA-N (2r,3r,4r,5r)-n-[(4-ethenylphenyl)methyl]-2,3,6-trihydroxy-5-methyl-4-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanamide Chemical compound O([C@H]([C@@H](CO)C)[C@H](O)[C@@H](O)C(=O)NCC=1C=CC(C=C)=CC=1)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O RPOKRGMOEWYIKB-ZFCLCKFASA-N 0.000 description 1
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 238000002738 Giemsa staining Methods 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 241000238371 Sepiidae Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000005456 alcohol based solvent Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000004956 cell adhesive effect Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000006196 deacetylation Effects 0.000 description 1
- 238000003381 deacetylation reaction Methods 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000000816 effect on animals Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 210000000224 granular leucocyte Anatomy 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000036647 reaction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000000192 social effect Effects 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
【0001】0001
【産業上の利用分野】この発明はキチン、キトサン、セ
ルロースあるいはそれらの誘導体を内面にコーティング
した細胞培養用シャーレに関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to a petri dish for cell culture whose inner surface is coated with chitin, chitosan, cellulose, or a derivative thereof.
【0002】0002
【従来の技術】組織から分散させた細胞は、細胞培養で
は個々の細胞をそれぞれ個々の生物体として微生物集団
と同様に取り扱うことを可能にする。更に細胞集団から
クローンを選択することにより遺伝的により均一な組成
をもつ細胞集団を得ることも可能である。BACKGROUND OF THE INVENTION Cells dispersed from tissues allow individual cells to be treated as individual organisms in cell culture, similar to microbial populations. Furthermore, by selecting clones from a cell population, it is also possible to obtain a cell population with a genetically more uniform composition.
【0003】現在細胞培養は組織培養の代表的な一分野
であり、体細胞の遺伝学、生理学、生化学、分子生物学
の研究上の有力な実験手段であるだけでなく、ワクチン
の製造やインターフェロンその他細胞の生産物の生成な
ど応用面でも価値が大きい。Currently, cell culture is a representative field of tissue culture, and is not only a powerful experimental tool for research in the genetics, physiology, biochemistry, and molecular biology of somatic cells, but also for the production of vaccines and other fields. It is also of great value in applications such as the production of interferon and other cellular products.
【0004】生物体内で組織を構築している細胞が培養
系に移された場合、生命活動を維持するためには、基質
に接着することが必要である。体内で基質の役割を担っ
ているものは細胞外基質と総称される物質である。[0004] When cells that construct tissues within an organism are transferred to a culture system, they must adhere to a substrate in order to maintain vital activity. Substances that play the role of matrix in the body are collectively called extracellular matrix.
【0005】細胞外基質の主要成分は、コラーゲン、プ
ロテオグリカン、エラスチン、ヒアルロン酸及びフィブ
ロネクチンやラミニンに代表される細胞接着性糖蛋白質
である。複雑な組成の細胞外基質をそのまま利用するこ
とにより、各種細胞の長期培養、分化形質の発現、機能
保持など、いままでにはできなかった培養系が可能とな
っている。生体組織から直接調製するものとしてbio
matrix がある。The main components of the extracellular matrix are collagen, proteoglycan, elastin, hyaluronic acid, and cell adhesive glycoproteins represented by fibronectin and laminin. By utilizing the complex extracellular matrix as it is, it has become possible to create culture systems that were not possible before, such as long-term culture of various cells, expression of differentiation traits, and maintenance of functions. bio, which is prepared directly from living tissue;
There is a matrix.
【0006】細胞接着活性をもつ人工合成物質をデザイ
ンして、培養基質として用いる手法が開発されつつある
。人工物質は熱安定性に優れ、一定品質のものを安定供
給できる利点をもつ。以前からポリリジンのコートが、
神経細胞の培養に利用されている。[0006] Techniques are being developed in which artificial synthetic substances with cell adhesion activity are designed and used as culture substrates. Artificial substances have excellent thermal stability and have the advantage of being able to provide a stable supply of constant quality. Polylysine coat has been used for a long time,
It is used for culturing nerve cells.
【0007】ラクトースを側鎖にもつ重合体(PVLA
)は肝細胞の接着物質として開発された。また、側鎖に
セロビオースをもつ重合体(PVCA)が、血管内皮細
胞の接着基質として開発されている。[0007] Polymers with lactose in their side chains (PVLA)
) was developed as an adhesive substance for hepatocytes. Furthermore, a polymer having cellobiose in its side chain (PVCA) has been developed as an adhesion substrate for vascular endothelial cells.
【0008】一方、細胞が接着・伸展する、培養に適し
た容器(材料表面)の開発には、たゆまぬ努力が注がれ
ている。1960年以前はガラス容器が主に用いられて
いたが、現在では、使いやすさ、再現性のよさなどの点
で、表面処理(プラズマ放電で表面を酸化する処理など
)を施したポリスチレン製の使い捨て容器が広汎に用い
られている。On the other hand, continuous efforts are being made to develop containers (material surfaces) suitable for culture to which cells can adhere and spread. Before 1960, glass containers were mainly used, but now polystyrene containers with surface treatments (such as oxidizing the surface using plasma discharge) are used for ease of use and good reproducibility. Disposable containers are widely used.
【0009】人工基質の開発は細胞と材料表面の相互作
用を人工的に制御して医療用に用いることができるため
、今後利用されるであろう多くの細胞とそれらに適した
人工基質、材料表面の開発が期待されている。[0009] The development of artificial substrates can be used for medical purposes by artificially controlling the interaction between cells and material surfaces. Therefore, many cells and artificial substrates and materials suitable for them will be used in the future. Development of the surface is expected.
【0010】0010
【発明が解決しようとする課題】細胞は、細胞外基質に
接着した後、増殖あるいは分化形質を発現する。接着そ
のものは、細胞の増殖や分化に必要だが、十分条件では
ない。各種細胞は種々の細胞外基質に接着するが、その
後の細胞の反応は接着性のよしあしで決まらないことが
多い。このことは、任意の細胞には、接着、増殖、ある
いは分化形質の発現に適した任意の細胞外基質があるこ
とを示している。Problems to be Solved by the Invention After cells adhere to the extracellular matrix, they proliferate or express differentiation characteristics. Adhesion itself is necessary but not a sufficient condition for cell proliferation and differentiation. Various types of cells adhere to various extracellular matrices, but subsequent cell reactions are often not determined by the adhesion properties. This indicates that any cell has any suitable extracellular matrix for adhesion, proliferation, or expression of differentiation traits.
【0011】生物体内で組織を構築している細胞が培養
系に移された場合、生命活動を維持するためには、基質
に接着することが必要である。そのため、生体内で基質
の役割を担っているもの(細胞外基質)や人工物質をデ
ザインした基質を用いて種々の組織由来の細胞をin
vivo に近い状態で培養する手法の開発が要求され
ている。[0011] When cells that construct tissues within an organism are transferred to a culture system, they must adhere to a substrate in order to maintain vital activity. Therefore, cells derived from various tissues can be injected using substrates that play the role of substrates in vivo (extracellular matrix) or artificial substances.
There is a need to develop a method for culturing in conditions close to those in vivo.
【0012】キチンは、甲殻類、昆虫類の組織支持体と
して自然界に広く分布して存在する天然ムコ多糖類であ
る。このキチンは、リゾチームにより加水分解されるこ
とから生分解性高分子として近年注目を集めている。Chitin is a natural mucopolysaccharide that is widely distributed in nature as a tissue support for crustaceans and insects. Chitin has recently attracted attention as a biodegradable polymer because it can be hydrolyzed by lysozyme.
【0013】このキチンの生体内消化性を利用してキチ
ンを手術用縫合糸(特開昭57−171712)、創傷
被覆保護剤(特開昭61−240963)などの医用材
料に応用する研究が盛んに行なわれている。[0013] Research has been conducted to utilize the in vivo digestibility of chitin to apply chitin to medical materials such as surgical sutures (Japanese Patent Laid-Open No. 57-171712) and wound dressing protectants (Japanese Patent Laid-Open No. 61-240963). It is actively practiced.
【0014】また、キチンの部分脱アセチル化物、及び
その他の誘導体において著しい免疫賦活性を発現するこ
とも見出されている。[0014] It has also been found that partially deacetylated products of chitin and other derivatives exhibit significant immunostimulatory activity.
【0015】更に、キチンを一成分とする生体内充填剤
は非常に良好な組織適合性を示し、動物に対する創傷治
癒効果能を有することが認められている。[0015] Furthermore, it has been recognized that biofillers containing chitin as one component exhibit very good tissue compatibility and have a wound healing effect on animals.
【0016】しかしながら、このキチンの創傷治癒効果
に対するメカニズムについては現在のところ全く不明で
あり、その解明のためには生体細胞をなるべくin v
ivo に近い状態で培養できるような容器、装置の開
発が必要不可欠である。[0016] However, the mechanism of chitin's wound healing effect is currently completely unknown.
It is essential to develop containers and equipment that allow culturing in conditions close to those in vivo.
【0017】一方、セルロースは天然に豊富に存在する
多糖であり、それらのアルキル、アシル誘導体は広く医
用材料に用いられている。On the other hand, cellulose is a naturally occurring polysaccharide, and its alkyl and acyl derivatives are widely used in medical materials.
【0018】[0018]
【課題を解決するための手段】この発明は、キチン、キ
トサン、セルロースあるいはそれらの誘導体に対して生
体に存在する細胞のin vivo での挙動をin
vitroで追及することができ、更に肝細胞、羊膜細
胞など分化形質を有する細胞を良好な状態で培養できる
などの機能を有するようなキチン、キトサン、セルロー
スあるいはそれらの誘導体(以下、これらを基質と呼ぶ
)を細菌培養用及び組織培養用のシャーレにコーティン
グした細胞培養用シャーレを得ることを目的とする。[Means for Solving the Problems] This invention aims to investigate the in vivo behavior of cells existing in living organisms toward chitin, chitosan, cellulose, or their derivatives.
Chitin, chitosan, cellulose, or their derivatives (hereinafter, these are used as substrates) that can be investigated in vitro and have the ability to culture cells with differentiated characteristics such as hepatocytes and amniotic cells in good conditions. The purpose of the present invention is to obtain a petri dish for cell culture in which a petri dish for bacterial culture and tissue culture is coated with the following.
【0019】[0019]
【作用】以下、基質をコーティングしたこの発明のシャ
ーレについて詳しく説明する。[Function] The petri dish of the present invention coated with a substrate will be explained in detail below.
【0020】1−3%の基質のギ酸溶液(1m1以下)
をペトリデイッシュ(一般細菌用)1008(日本ベク
トン・デイッキンソン社、35x10mm){ポリスチ
レンシャーレ(細菌培養用)}及び、ファルコン組織培
養デイッシュ3001(日本ベクトン・デイッキンソン
社、35x10mm) {ポリスチレンシャーレ(組織
培養用)}へ注ぎ、底面に均一に塗布した。次に、この
シャーレを室温で1時間〜1日放置し、フィルムが収縮
しない程度にギ酸を蒸発させた。1-3% substrate in formic acid solution (less than 1 ml)
Petri dish (for general bacteria) 1008 (Japan Becton Dickinson Co., Ltd., 35 x 10 mm) {Polystyrene petri dish (for bacterial culture)} and Falcon tissue culture dish 3001 (Japan Becton Dickinson Co., Ltd., 35 x 10 mm) {Polystyrene petri dish (tissue culture) (for use) and apply it evenly to the bottom. Next, this Petri dish was left at room temperature for 1 hour to 1 day to evaporate the formic acid to the extent that the film did not shrink.
【0021】その後、シャーレ内にエタノール、メタノ
ール等のアルコール類と水酸化ナトリウム、水酸化カリ
ウム等の水酸化物水溶液との混合溶媒(6/1〜1/1
v/v)、アルコール類とアンモニア水などの有機塩
基水溶液との混合溶媒(6/1 〜1/1 v/v)、
あるいはエタノール、メタノール等のアルコール溶媒、
好ましくはメタノールまたはメタノール/1M水酸化ナ
トリム水溶液(4/1 v/v)の混合溶媒を1〜10
ml注ぎ、0.5 〜2時間放置した。[0021] After that, in a petri dish, a mixed solvent (6/1 to 1/1
v/v), a mixed solvent of alcohol and an aqueous organic base solution such as aqueous ammonia (6/1 to 1/1 v/v),
Or alcohol solvents such as ethanol and methanol,
Preferably methanol or a mixed solvent of methanol/1M sodium hydroxide aqueous solution (4/1 v/v)
ml and left for 0.5 to 2 hours.
【0022】メタノールで2、3回洗浄後、コートした
フィルムの様子をみながら0.5 〜2時間風乾した。
尚、この際乾燥し過ぎるとフィルムの一部がシャーレか
らはがれる。最後にシャーレを蒸留水で十分に洗浄し、
細胞培養試験に用いた。この方法で調製したシャーレは
フィルムの接着性、透明度共に良好であった。After washing with methanol two or three times, the coated film was air-dried for 0.5 to 2 hours while checking its appearance. At this time, if the film is too dry, part of the film will peel off from the petri dish. Finally, wash the petri dish thoroughly with distilled water,
Used for cell culture tests. The petri dish prepared by this method had good film adhesion and transparency.
【0023】アセチルセルロース−イソシアネート共重
合体はジメチルスルホキシド(DMSO)あるいはDM
SOとアルコールとの混合溶媒(1/2 〜3/1 v
/v)、好ましくはDMSO/メタノール(1/1 v
/v)混合溶媒に共重合体(0.1〜1.0 %)を溶
解し、その0.2 〜1.0ml をシャーレに塗布し
、減圧乾燥後、蒸留水で洗浄した。The acetylcellulose-isocyanate copolymer is dimethyl sulfoxide (DMSO) or DM
Mixed solvent of SO and alcohol (1/2 to 3/1 v
/v), preferably DMSO/methanol (1/1 v)
/v) A copolymer (0.1 to 1.0%) was dissolved in a mixed solvent, and 0.2 to 1.0 ml of the copolymer was applied to a Petri dish, dried under reduced pressure, and then washed with distilled water.
【0024】直径35mmのポリスチレンシャーレ(細
菌培養用)、ポリスチレンシャーレ(組織培養用)及び
この発明の細胞培養用シャーレを用いて細胞培養試験を
行なった。A cell culture test was conducted using a polystyrene petri dish (for bacterial culture), a polystyrene petri dish (for tissue culture), and a cell culture petri dish of the present invention having a diameter of 35 mm.
【0025】細胞として、マウス繊維芽細胞3T3(J
CRB)とマウスマクロファージ株A640 −BB−
2(谷川ら、J. Cell.Physiol.120
,242, 1984)を使用した。ポリスチレンシャ
ーレ(細菌培養用)、ポリスチレンシャーレ(組織培養
用)並びにキチン、キトサン、セルロースあるいはそれ
らの誘導体をコーティングしたシャーレそれぞれに上記
細胞を2×105 個撒いた。[0025] As cells, mouse fibroblast cells 3T3 (J
CRB) and mouse macrophage line A640 -BB-
2 (Tanikawa et al., J. Cell. Physiol. 120
, 242, 1984) was used. 2×10 5 cells of the above cells were seeded in each of a polystyrene petri dish (for bacterial culture), a polystyrene petri dish (for tissue culture), and a petri dish coated with chitin, chitosan, cellulose, or their derivatives.
【0026】尚、ダルベッコ改変イーグル培地にウシ胎
児血清を7.5 %量となるように加えた。マウス繊維
芽細胞3T3は37℃、マウスマクロファージ株A64
0 −BB−2は39℃の炭酸ガス培養器で5日間培養
した。[0026] Fetal bovine serum was added to Dulbecco's modified Eagle's medium at a concentration of 7.5%. Mouse fibroblast 3T3 at 37°C, mouse macrophage line A64
0-BB-2 was cultured for 5 days in a carbon dioxide incubator at 39°C.
【0027】培養1日目と5日目に各シャーレを2%ホ
ルマリンと100 %メタノールで固定し、ギムザ染色
し、光学顕微鏡(400倍)で観察した。[0027] On the first and fifth days of culture, each petri dish was fixed with 2% formalin and 100% methanol, stained with Giemsa, and observed under an optical microscope (400x magnification).
【0028】キチン、キトサン、セルロースあるいはそ
れらの誘導体の創傷治癒効果に対するメカニズムの解明
については以下の方法で検討した。
1)生体の炎症局所より採取した浸出液をキチン誘導体
でコーティングしたシャーレに撒いて、培養液を加え、
37℃で数日間培養し、細胞の種類や数、形態の特徴等
を観察する。
2)炎症部位に浸出してくると考えられている多形核白
血球、単球、リンパ球、あるいは創傷治癒に関係する繊
維芽細胞などの株化細胞を本シャーレに撒いて、付着性
、増殖性、機能の発現の有無、細胞の活性化の程度(生
理活性物質の分泌の有無)などを検討する。
3)これらの結果を統合することにより、炎症局所にお
ける体液性変化、細胞変化を具体的に把握することがで
き、炎症局所の反応の推定を可能にすると共に創傷治癒
におけるキチンの働きを理解する。The following method was used to elucidate the mechanism of the wound healing effect of chitin, chitosan, cellulose, or their derivatives. 1) Sprinkle the exudate collected from the inflamed area of the living body on a petri dish coated with a chitin derivative, add the culture solution,
Culture at 37°C for several days and observe cell types, numbers, morphological characteristics, etc. 2) Established cell lines such as polymorphonuclear leukocytes, monocytes, and lymphocytes, which are thought to leak into inflammation sites, or fibroblasts, which are involved in wound healing, are spread in this petri dish to determine their adhesion and proliferation. Examine the nature of the cell, the presence or absence of function expression, the degree of cell activation (presence or absence of secretion of physiologically active substances), etc. 3) By integrating these results, it is possible to specifically understand the humoral changes and cellular changes in the inflamed area, making it possible to estimate the response of the inflamed area and understanding the role of chitin in wound healing. .
【0029】[0029]
【実施例】以下、実施例をあげてこの発明を更に詳しく
説明する。[Examples] The present invention will be explained in more detail below with reference to Examples.
【0030】実施例1
1%のイカ甲キチンギ酸溶液(0.3ml)をポリスチ
レンシャーレ(組織培養用)内へ注ぎ、底面に均一に塗
布し、室温で1時間放置した。その後、シャーレ内にメ
タノールを5ml 注ぎ、30分放置した。メタノール
で2、3回洗浄後、30分放置した。最後にシャーレを
蒸留水で十分に洗浄してこの発明の培養用シャーレを得
、細胞培養試験に用いた。Example 1 A 1% squid shell chitingic acid solution (0.3 ml) was poured into a polystyrene Petri dish (for tissue culture), uniformly applied to the bottom surface, and left at room temperature for 1 hour. Thereafter, 5 ml of methanol was poured into the petri dish and left for 30 minutes. After washing with methanol two or three times, it was left for 30 minutes. Finally, the petri dish was thoroughly washed with distilled water to obtain a culture dish of the present invention, which was used in a cell culture test.
【0031】上記で得たこの発明のシャーレでマウス繊
維芽細胞およびマウスマクロファージ株の培養を行ない
、その結果を光学顕微鏡(400倍)で観察したところ
、マウス繊維芽細胞は、1日目には図1のように細胞が
十分伸展し、5日目には図2のように増殖してシャーレ
全体を覆い尽くした。マウスマクロファージ株について
は、図3のように培養1日目に細胞の形態は義足樹枝状
に変化した。[0031] Mouse fibroblasts and mouse macrophage strains were cultured in the above-obtained petri dish of the present invention, and the results were observed under an optical microscope (400x magnification). The cells spread sufficiently as shown in Figure 1, and on the fifth day they proliferated to cover the entire Petri dish as shown in Figure 2. Regarding the mouse macrophage strain, the cell morphology changed to a prosthetic dendritic shape on the first day of culture, as shown in Figure 3.
【0032】実施例2
脱アセチル化度27%の部分脱アセチル化キチン(DA
C−27)の1%ギ酸溶液(0.3ml)を特殊加工し
たポリスチレンシャーレへ注ぎ、底面に均一に塗布し、
室温で約5時間放置したExample 2 Partially deacetylated chitin (DA) with a degree of deacetylation of 27%
Pour a 1% formic acid solution (0.3 ml) of C-27) into a specially processed polystyrene petri dish and apply it evenly to the bottom.
Leave it at room temperature for about 5 hours
【0033】その後、シャーレ内にメタノール/1M水
酸化ナトリウム水溶液(4/1 v/v)混合溶媒を5
ml 注ぎ、2時間放置した。メタノールで2、3回洗
浄後、2時間放置した。最後にシャーレを蒸留水で十分
に洗浄して培養用シャーレを得、細胞培養試験に用いた
。[0033] Thereafter, 55% of methanol/1M sodium hydroxide aqueous solution (4/1 v/v) mixed solvent was placed in a petri dish.
ml and left for 2 hours. After washing with methanol two or three times, it was left to stand for 2 hours. Finally, the petri dish was thoroughly washed with distilled water to obtain a culture dish, which was used in the cell culture test.
【0034】同様の方法で、脱アセチル化度66%及び
88%の部分脱アセチル化キチン(DAC−66及びD
AC−88)についてもシャーレを調製し、細胞培養試
験に用いた。In a similar manner, partially deacetylated chitin (DAC-66 and D
A petri dish was also prepared for AC-88) and used in the cell culture test.
【0035】部分脱アセチル化キチン(DAC−27、
DAC−66、DAC−88)をコーティングしたシャ
ーレで培養したところ、マウス繊維芽細胞の接着性に差
が見られた。即ち、DAC−88>DAC−27>DA
C−66の順に良好な接着性を示し、用いる基質の種類
により細胞の接着性をコントロールできた。Partially deacetylated chitin (DAC-27,
When cultured in Petri dishes coated with DAC-66, DAC-88), differences in the adhesion of mouse fibroblasts were observed. That is, DAC-88>DAC-27>DA
C-66 exhibited good adhesion, and cell adhesion could be controlled by the type of substrate used.
【0036】マウスマクロファージ株に対する接着性は
、DAC−27、DAC−88の場合、イカ甲キチンの
時と同様の細胞の義足樹枝状の変化が認められた。しか
し、DAC−66の場合は、細胞は丸いままだった。Regarding adhesion to mouse macrophage strains, in the case of DAC-27 and DAC-88, the same dendritic changes in the cells as in the case of squid carapace chitin were observed. However, in the case of DAC-66, the cells remained round.
【0037】実施例3
0.5 %のアセチルセルロース−ジフェニルメタンジ
イソシアナート(MDI)ブロック共重合体のDMSO
−メタノール(1:1)混合溶液(0.3ml)をポリ
スチレンシャーレ(組織培養用)へ注ぎ、底面に均一に
塗布し、室温で4時間、続いて70℃で2時間真空乾燥
した。その後、シャーレを蒸留水で十分に洗浄し、細胞
培養試験に用いた。Example 3 0.5% acetylcellulose-diphenylmethane diisocyanate (MDI) block copolymer in DMSO
- A mixed solution (0.3 ml) of methanol (1:1) was poured into a polystyrene petri dish (for tissue culture), applied uniformly to the bottom surface, and vacuum-dried at room temperature for 4 hours and then at 70° C. for 2 hours. Thereafter, the petri dish was thoroughly washed with distilled water and used for a cell culture test.
【0038】アセチルセルロース−MDIブロック共重
合体をコーティングしたシャーレで培養したところ、マ
ウス繊維芽細胞は、1日目には細胞が十分伸展し、5日
目には増殖してシャーレ全体を覆い尽くした。マウスマ
クロファージ株についても、培養1日目に細胞は十分に
伸展していた。細胞の着床能、増殖状態は従来用いられ
ているポリスチレンシャーレ(組織培養用)よりも優れ
ていた。When cultured in a Petri dish coated with acetylcellulose-MDI block copolymer, the mouse fibroblast cells expanded sufficiently on the first day and proliferated to cover the entire Petri dish on the fifth day. Ta. The cells of the mouse macrophage strain were also sufficiently spread on the first day of culture. The cell implantation ability and proliferation state were superior to that of conventionally used polystyrene petri dishes (for tissue culture).
【0039】比較例1
ポリスチレンシャーレ(細菌培養用)を用いて各種細胞
を培養したところ、マウス繊維芽細胞は、細胞の着床性
が悪く、培養には適さなかった。マウスマクロファージ
株についても細胞の着床性が悪かった。Comparative Example 1 When various cells were cultured using a polystyrene petri dish (for bacterial culture), mouse fibroblasts had poor cell implantation properties and were not suitable for culture. The mouse macrophage strain also showed poor cell implantation.
【0040】比較例2
ポリスチレンシャーレ(組織培養用)を用いて各種細胞
を培養したところ、マウス繊維芽細胞は、1日目には図
4のように、細胞が十分伸展し、5日目には図5のよう
に増殖してシャーレ全体を覆い尽くした。マウスマクロ
ファージ株についても1日目で図6のように細胞が十分
伸展した。Comparative Example 2 When various cells were cultured using a polystyrene petri dish (for tissue culture), the mouse fibroblast cells expanded sufficiently on the first day, as shown in Figure 4, and on the fifth day. The cells proliferated and covered the entire Petri dish as shown in Figure 5. The cells of the mouse macrophage strain also spread sufficiently on the first day, as shown in Figure 6.
【0041】[0041]
【発明の効果】この発明において作製した基質コーティ
ングシャーレで培養しても、細胞親和性が良好で、細胞
に対する毒性が全くないことが認められた。また、細胞
がシャーレに付着しやすくなっているので、生存し続け
ている細胞が多くなり、形態の観察も容易であった。Effects of the Invention Even when cultured in the substrate-coated petri dish prepared in the present invention, it was found that the cell compatibility was good and there was no toxicity to the cells. In addition, since the cells were more likely to adhere to the Petri dish, more cells remained alive, making it easier to observe their morphology.
【0042】マクロファージの株をイカ甲キチンコーテ
ィングシャーレで培養した際に、マクロファージの形態
がポリスチレンシャーレ(組織培養用)で培養したとき
と異なった特徴が認められたことから、前述の動物に対
する創傷治癒効果との関連性が示唆される。[0042] When a macrophage strain was cultured in a cuttlefish shell chitin-coated petri dish, the morphology of the macrophages was found to have different characteristics from that when cultured in a polystyrene petri dish (for tissue culture). This suggests a relationship with the effects.
【0043】キチンあるいはキチン誘導体による持続的
な刺激により従来認められなかった活性化等が期待でき
る。[0043] Continuous stimulation with chitin or chitin derivatives can be expected to cause activation that has not been previously observed.
【0044】これらの基質でコーティングしたシャーレ
はいずれも透明度が良く、ギムザ染色による細胞の染色
性にも影響しないことから、細胞培養用のシャーレとし
て広範囲の用途に有用である。Petri dishes coated with these substrates all have good transparency and do not affect the stainability of cells by Giemsa staining, so they are useful for a wide range of applications as petri dishes for cell culture.
【0045】更に、本発明により下記のような社会的効
果が期待される。
1)キチン及びキチン誘導体が手術用縫合糸、創傷被覆
保護剤などの医用材料に応用されているが、キチン及び
キチン誘導体の組織や細胞に及ぼす直接的な影響をシャ
ーレ内で再現することにより、基礎的データを得ること
が可能となる。
2)いままで以上に多種類のシャーレを用意することに
より、今までシャーレの中では培養維持が困難であった
細胞(分化形質を有する細胞:肝細胞、羊膜細胞など)
が、良好な状態で培養することが可能である。又、今ま
でのシャーレでは認められなかった性状の細胞を見出す
ことができる期待できる。更に、分化形質を有するマク
ロファージがこのシャーレで培養できたことから、分化
した形質を失わずにこれらの細胞を長期間培養できるこ
とも示唆される。
3)より広範囲の動物細胞をキチンあるいはキチン誘導
体コーティングシャーレで培養できれば、培養細胞を使
用することにより、余分な動物を犠牲にする必要がなく
なり、動物愛護の面からも望ましいことであろう。Furthermore, the following social effects are expected from the present invention. 1) Chitin and chitin derivatives have been applied to medical materials such as surgical sutures and wound dressings, but by reproducing the direct effects of chitin and chitin derivatives on tissues and cells in a petri dish, It becomes possible to obtain basic data. 2) By preparing more types of petri dishes than ever before, cells that were previously difficult to maintain in culture in petri dishes (cells with differentiated traits: hepatocytes, amniotic cells, etc.)
However, it is possible to culture it under good conditions. In addition, it is expected that cells with characteristics that have not been observed in conventional petri dishes will be found. Furthermore, the fact that macrophages with differentiated traits could be cultured in this petri dish suggests that these cells can be cultured for long periods without losing their differentiated traits. 3) If a wider range of animal cells could be cultured in petri dishes coated with chitin or chitin derivatives, the use of cultured cells would eliminate the need to sacrifice extra animals, which would be desirable from the standpoint of animal welfare.
【図1】マウス繊維芽細胞3T3をこの発明のシャーレ
を用いて培養した培養1日目の形態を示す光学顕微鏡写
真(400倍)である。FIG. 1 is an optical micrograph (400x magnification) showing the morphology of mouse fibroblasts 3T3 on the first day of culture using the petri dish of the present invention.
【図2】マウス繊維芽細胞3T3をこの発明のシャーレ
を用いて培養した培養5日目の形態を示す光学顕微鏡写
真(400倍)である。FIG. 2 is an optical micrograph (400x magnification) showing the morphology of mouse fibroblasts 3T3 on day 5 of culture using the petri dish of the present invention.
【図3】マウスマクロファージ株A640 −BB2を
この発明のシャーレを用いて培養した培養1日目の形態
を示す光学顕微鏡写真(400倍)である。FIG. 3 is an optical micrograph (400x magnification) showing the morphology of mouse macrophage strain A640-BB2 cultured on the first day of culture using the petri dish of the present invention.
【図4】マウス繊維芽細胞3T3をポリスチレンシャー
レ(組織培養用)を用いて培養した培養1日目の形態を
示す光学顕微鏡写真(400倍)である。FIG. 4 is an optical micrograph (400x magnification) showing the morphology of mouse fibroblast cells 3T3 cultured on the first day of culture using a polystyrene petri dish (for tissue culture).
【図5】マウス繊維芽細胞3T3をポリスチレンシャー
レ(組織培養用)を用いて培養した培養5日目の形態を
示す光学顕微鏡写真(400倍)である。FIG. 5 is an optical micrograph (400x magnification) showing the morphology of mouse fibroblast 3T3 cells cultured on day 5 of culture using a polystyrene petri dish (for tissue culture).
【図6】マウスマクロファージ株A640 −BB2を
ポリスチレンシャーレ(組織培養用)を用いて培養した
培養1日目の形態を示す光学顕微鏡写真(400倍)で
ある。FIG. 6 is an optical micrograph (400x magnification) showing the morphology of the mouse macrophage strain A640-BB2 on the first day of culture in a polystyrene petri dish (for tissue culture).
Claims (1)
はそれらの誘導体を内面にコーティングしたことを特徴
とする細胞培養用シャーレ[Claim 1] A petri dish for cell culture, characterized in that the inner surface is coated with chitin, chitosan, cellulose, or a derivative thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8148691A JPH04293481A (en) | 1991-03-19 | 1991-03-19 | Petri dish for cell culture |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8148691A JPH04293481A (en) | 1991-03-19 | 1991-03-19 | Petri dish for cell culture |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04293481A true JPH04293481A (en) | 1992-10-19 |
Family
ID=13747736
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8148691A Pending JPH04293481A (en) | 1991-03-19 | 1991-03-19 | Petri dish for cell culture |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04293481A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7074612B2 (en) * | 2002-03-06 | 2006-07-11 | National Institute Of Agrobiological Sciences | Insect cell primary culture medium, extracellular matrix, and process of preparing an insect culture cell line in a short period of time using the medium and matrix |
JP2015149980A (en) * | 2014-02-19 | 2015-08-24 | 凸版印刷株式会社 | Culture apparatus, and manufacturing method thereof |
-
1991
- 1991-03-19 JP JP8148691A patent/JPH04293481A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7074612B2 (en) * | 2002-03-06 | 2006-07-11 | National Institute Of Agrobiological Sciences | Insect cell primary culture medium, extracellular matrix, and process of preparing an insect culture cell line in a short period of time using the medium and matrix |
JP2015149980A (en) * | 2014-02-19 | 2015-08-24 | 凸版印刷株式会社 | Culture apparatus, and manufacturing method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Campuzano et al. | Scaffolds for 3D cell culture and cellular agriculture applications derived from non-animal sources | |
Fakhry et al. | Chitosan supports the initial attachment and spreading of osteoblasts preferentially over fibroblasts | |
Dhiman et al. | Characterization and evaluation of chitosan matrix for in vitro growth of MCF-7 breast cancer cell lines | |
Liang et al. | An in situ formed biodegradable hydrogel for reconstruction of the corneal endothelium | |
Risbud et al. | Growth modulation of fibroblasts by chitosan-polyvinyl pyrrolidone hydrogel: implications for wound management? | |
Lai et al. | Nanoscale modification of porous gelatin scaffolds with chondroitin sulfate for corneal stromal tissue engineering | |
Ma et al. | Enhanced biological stability of collagen porous scaffolds by using amino acids as novel cross-linking bridges | |
Mao et al. | Study of novel chitosan‐gelatin artificial skin in vitro | |
Taghiabadi et al. | Fabrication and characterization of spongy denuded amniotic membrane based scaffold for tissue engineering | |
Chupa et al. | Vascular cell responses to polysaccharide materials:: in vitro and in vivo evaluations | |
Daamen et al. | Preparation and evaluation of molecularly-defined collagen–elastin–glycosaminoglycan scaffolds for tissue engineering | |
EP2633033B1 (en) | Cell culture material based on microbial cellulose | |
Lai et al. | Adhesion, phenotypic expression, and biosynthetic capacity of corneal keratocytes on surfaces coated with hyaluronic acid of different molecular weights | |
Tığlı et al. | Evaluation of alginate-chitosan semi IPNs as cartilage scaffolds | |
Thein‐Han et al. | Chitosan scaffolds for in vitro buffalo embryonic stem‐like cell culture: An approach to tissue engineering | |
Sakai et al. | Enzymatically crosslinked carboxymethylcellulose–tyramine conjugate hydrogel: cellular adhesiveness and feasibility for cell sheet technology | |
Lai | Biofunctionalization of gelatin microcarrier with oxidized hyaluronic acid for corneal keratocyte cultivation | |
Farrugia et al. | Harnessing chondroitin sulphate in composite scaffolds to direct progenitor and stem cell function for tissue repair | |
AU2002223995A1 (en) | Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants | |
Chou et al. | Relationships between surface roughness/stiffness of chitosan coatings and fabrication of corneal keratocyte spheroids: Effect of degree of deacetylation | |
EP1115432B1 (en) | Dermal scaffold using neutralized chitosan sponge or neutralized chitosan/collagen mixed sponge | |
CN111253579A (en) | Preparation method and application of glucan-hyaluronic acid hydrogel for three-dimensional cell culture | |
JP2003024056A (en) | Process for providing readily usable and homogeneously dispersed extracellular matrix as substrate | |
Wang et al. | Extracellular matrix mimicking dynamic interpenetrating network hydrogel for skin tissue engineering | |
Kuo et al. | Surface modification with peptide for enhancing chondrocyte adhesion and cartilage regeneration in porous scaffolds |